MML Investors Services
ALXN

MML Investors Services’s Alexion Pharmaceuticals ALXN Stock Holding History

MML Investors Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,954
Closed -$726K – 2023
2021
Q2 		$726K Sell
3,954
-9,583
-71% -$1.64M 0.01% 1150
2021
Q1 		$2.07M Sell
13,537
-8,260
-38% -$1.28M 0.02% 646
2020
Q4 		$3.41M Sell
21,797
-920
-4% -$118K 0.04% 409
2020
Q3 		$2.6M Buy
22,717
+340
+2% +$36.7K 0.03% 440
2020
Q2 		$2.51M Sell
22,377
-3,342
-13% -$355K 0.03% 421
2020
Q1 		$2.31M Buy
25,719
+9,181
+56% +$901K 0.04% 378
2019
Q4 		$1.79M Buy
16,538
+4,515
+38% +$483K 0.03% 517
2019
Q3 		$1.18M Buy
12,023
+3,439
+40% +$388K 0.02% 615
2019
Q2 		$1.12M Buy
8,584
+1,392
+19% +$179K 0.02% 676
2019
Q1 		$972K Buy
7,192
+1,184
+20% +$147K 0.02% 710
2018
Q4 		$585K Buy
6,008
+666
+12% +$78.7K 0.01% 835
2018
Q3 		$743K Buy
5,342
+583
+12% +$73.1K 0.01% 802
2018
Q2 		$591K Buy
4,759
+245
+5% +$28.6K 0.01% 774
2018
Q1 		$503K Sell
4,514
-404
-8% -$48.3K 0.01% 844
2017
Q4 		$588K Buy
4,918
+1,230
+33% +$150K 0.01% 758
2017
Q3 		$517K Sell
3,688
-875
-19% -$119K 0.01% 771
2017
Q2 		$555K Buy
4,563
+192
+4% +$22.3K 0.01% 727
2017
Q1 		$530K Buy
+4,371
New +$564K 0.01% 433

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

MML Investors Services's ALXN Position: Q3 2021 in Review

MML Investors Services sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 3,954 shares — an estimated $726K sold.

MML Investors Services first reported a position in ALXN in Q1 2017 and held it in 18 quarters. The position peaked at $3.41M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • MML Investors Services reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • MML Investors Services sold 3,954 Alexion Pharmaceuticals shares in Q3 2021, an estimated $726K.
  • MML Investors Services first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 18 quarters.
  • MML Investors Services's Alexion Pharmaceuticals position peaked at $3.41M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on MML Investors Services's 13F filing for Q3 2021, filed 15 Nov 2021.